Neoadjuvant Nivolumab Plus Chemotherapy and Response-Adaptive Therapy for HPV Oropharyngeal Cancer
This phase 2 nonrandomized clinical trial evaluates effectiveness and tolerance of neoadjuvant nivolumab, nab-paclitaxel, and carboplatin followed by response-adaptive therapy in patients with human...
jamanetwork.com